fluorodeoxyglucose f18 has been researched along with xylometazoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Iguchi, M; Iwasa, H; Matsumoto, T; Miyatake, K; Nakaji, K; Nishimori, M; Nitta, N; Tamura, M; Yamagami, T; Yamanishi, T; Yoshimatsu, R | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and xylometazoline
Article | Year |
---|---|
18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Imidazoles; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |